Long-term outcome of living-unrelated donor kidney transplantation.
Prabhakar
K S
KS
Department of Renal Medicine, Singapore General Hospital, Singapore.
Vathsala
A
A
Woo
K T
KT
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D015331:Cohort Studies; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005190:Family; D005260:Female; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007194:India; D007239:Infections / Q000453:epidemiology; D016030:Kidney Transplantation / Q000276:immunology / Q000401:mortality / Q000502:physiology*; D019520:Living Donors; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D011239:Prednisolone / Q000627:therapeutic use; D012846:Singapore; D015996:Survival Rate; D013997:Time Factors; D017211:Treatment Failure; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; D001379:Azathioprine; D008775:Methylprednisolone